We are live on
!
Find out more
SCM
Suvretta Capital Management Portfolio holdings
AUM
$3.69B
1-Year Est. Return
86.67%
This Fund
S&P 500
1 Year Est. Return
+86.67%
AUM
$3.69B
AUM Growth
-$324M
(-8.1%)
Holding
108
Top Buys
| 1 | +$210M | |
| 2 | +$54.2M | |
| 3 | +$53.4M | |
| 4 |
Crinetics Pharmaceuticals
CRNX
|
+$46.6M |
| 5 |
Performance Food Group
PFGC
|
+$35.4M |
Top Sells
| 1 | +$131M | |
| 2 | +$96.7M | |
| 3 | +$64.7M | |
| 4 |
ServiceNow
NOW
|
+$59.7M |
| 5 |
Salesforce
CRM
|
+$53M |
Sector Composition
| 1 | Healthcare | 69.4% |
| 2 | Technology | 7.12% |
| 3 | Consumer Discretionary | 6.25% |
| 4 | Financials | 4.38% |
| 5 | Consumer Staples | 4.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Arcutis Biotherapeutics
ARQT
$3.46B
| $290M | 7.88% |
12,327,000
+363,000
|
|
||
|
MANE
2
Veradermics Inc
MANE
$4.93B
| $263M | 7.14% |
+4,168,970
|
|
||
3
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$786B
| $228M | 6.17% |
350,000
-450,000
|
|
||
|
PVLA
4
Palvella Therapeutics
PVLA
$2.14B
| $144M | 3.9% |
1,153,496
+261,096
|
|
||
|
APLS
5
DELISTED
Apellis Pharmaceuticals
APLS
| $142M | 3.84% |
3,518,471
-620,955
|
|
||
6
Legend Biotech
LEGN
$4.38B
| $137M | 3.72% |
7,581,029
+972,400
|
|
||
7
Benitec Biopharma
BNTC
$439M
| $123M | 3.34% |
11,548,351
|
|
||
8
Capricor Therapeutics
CAPR
$1.14B
| $116M | 3.15% |
3,818,600
+2,032,990
|
|
||
9
Immatics
IMTX
$1.26B
| $110M | 2.99% |
11,190,129
|
|
||
10
Arcus Biosciences
RCUS
$3.4B
| $109M | 2.95% |
5,030,993
-157,865
|
|
||
11
EyePoint Inc
EYPT
$1.14B
| $107M | 2.9% |
8,296,375
+468,690
|
|
||
12
ArriVent BioPharma
AVBP
$1.5B
| $102M | 2.75% |
4,401,083
+295,048
|
|
||
13
TSMC
TSM
$2.15T
| $101M | 2.74% |
298,707
+27,306
|
|
||
14
NVIDIA
NVDA
$5.06T
| $100M | 2.72% |
574,656
+43,756
|
|
||
15
Meta Platforms (Facebook)
META
$1.72T
| $97.1M | 2.63% |
169,707
+638
|
|
||
|
KALV
16
DELISTED
KalVista Pharmaceuticals
KALV
| $96M | 2.6% |
4,768,712
|
|
||
17
GE Aerospace
GE
$362B
| $88M | 2.39% |
310,262
|
|
||
18
Biohaven
BHVN
$2.18B
| $87M | 2.36% |
10,286,937
|
|
||
19
Sysco
SYY
$39.4B
| $82.7M | 2.24% |
1,159,156
+75,366
|
|
||
20
MGM Resorts International
MGM
$11.9B
| $79.9M | 2.17% |
2,158,800
+956,730
|
|
||
21
Compass Therapeutics
CMPX
$384M
| $75.7M | 2.05% |
14,307,379
+125,000
|
|
||
22
Home Depot
HD
$346B
| $72.9M | 1.98% |
221,590
-19,271
|
|
||
23
Kura Oncology
KURA
$969M
| $69.7M | 1.89% |
8,575,422
|
|
||
24
Monte Rosa Therapeutics
GLUE
$1.95B
| $69.5M | 1.89% |
4,226,809
+866,809
|
|
||
25
Bank of America
BAC
$432B
| $63.1M | 1.71% |
1,295,245
-222,385
|
|
Similar funds
CAM
BB
GCM
EPIM
TGA
SLG
HIM
LWCA